-
Alternative_name
N-[3-fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; XL-880; GSK1363089G
-
Description
Foretinib is an ATP-competitive multi-kinase inhibitor that suppresses the activity of hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor-2 (VEGFR-2). In addition, Foretinib suppresses angiogenesis and lymphangiogenesis by blocking VEGFR-2/3 and TIE-2 signaling
-
CAS Number
849217-64-7
-
Structure Available
Yes
-
Molecular Formula
C₃₄H₃₄F₂N₄O₆
-
Molecular Weight
632.65
-
Cell Permeable
Yes
-
Purity
≥98% by HPLC
-
Solubilities
DMSO (>50 mg/ml)
-
Handling
Protect from air and light
-
Tag Line
An ATP-competitive multi-kinase inhibitor
-
Storage Condition
-20°C
-
Shipping Condition
Gel pack
-
Shelf Life
36 months
-
PubChem CID
42642645
-
-
SMILES
COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F
-
InChi
InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)
-
InChi Key
CXQHYVUVSFXTMY-UHFFFAOYSA-N
-
-
MSDS Available
Yes